The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cystic fibrosis
Open accessAbstract
Over 7000 people have cystic fibrosis in the United Kingdom.It is the commonest genetically inherited disease in white populations (1 in 2500 newborns), although it is increasingly recognised as being important in non-white populations.However, most general practitioners have only one or two patients on their list, and as management generally takes place in specialist centres, many general paediatricians will be involved in the care of only a small number of patients.Progress in our understanding of the disease and the impact of this on management has been rapid over the past 20 years.Cystic fibrosis used to be a digestive and lung disease of young children but more recently has become a complex, multisystem disease extending into adulthood; there will soon be more adults than children with the condition.The predicted median survival for babies born in the 21st century is now more than 50 years.1 This increased survival-together with changes in standard treatment, the increasing implementation of newborn screening, and the focus on new therapeutic strategies-leads us to consider that an update on this albeit relatively rare disease may be of general interest. What is the cause of cystic fibrosis?Cystic fibrosis is an autosomal recessive disease.It is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. 2 The commonest mutation is the deletion of phenylalanine at codon 508 (phe508del, until recently known as ΔF508).This occurs in about 70% of patients with cystic fibrosis (www.ornl.gov/sci/techresources/Human_Genome/posters/chromosome/cftr.shtml).Over 1600 mutations of the CFTR gene have been described.Different mutations in this gene have varying effects on CFTR function and can result in different phenotypes of the disease.Some mutations will result in milder forms of the disease, although there is not enough evidence about these rarer mutations to counsel patients about their prognosis.The CFTR protein is expressed in many cells and has several functions, not all of which have been linked with disease.The primary function of the CFTR protein is as an ion channel that regulates liquid volume on epithelial surfaces through chloride secretion and inhibition of sodium absorption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Progress and potential in organoid research
Rossi, G., Manfrin, A., & Lutolf, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0051-9 · Cited by 1,182
Glutathione dysregulation and the etiology and progression of human diseases
Ballatori, N., Krance, S. M., Notenboom, S., Shi, S., Tieu, K., & Hammond, C. L. (2009) · bchm · doi:10.1515/bc.2009.033 · Cited by 1,114
Electrospinning for drug delivery applications: A review
Luraghi, A., Peri, F., & Moroni, L. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.033 · Cited by 746
mRNA-based therapeutics: looking beyond COVID-19 vaccines
Parhiz, H., Atochina-Vasserman, E. N., & Weissman, D. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02444-3 · Cited by 279
Metadata
- Authors
- Davies, J. C., Alton, E. W. F. W., & Bush, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2007-12-13
- Volume
- 335
- Issue
- 7632
- Pages
- 1255-1259
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2411292621
- Cited by
- 306
- References
- 2
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cystic fibrosis. https://app.cochat.ai/papers/10.1136/bmj.39391.713229.ad
- The paper
- Davies, J. C., Alton, E. W. F. W., & Bush, A. (2007). Cystic fibrosis. BMJ. https://doi.org/10.1136/bmj.39391.713229.ad
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.